10-Q Filing

LIFESTANCE HEALTH GROUP, INC. CIK: 1845257 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-023899`
Period End Date	20220930
Filing Date	20221109
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	lfst-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 88 Cash Flow Statement 76 Stockholders Equity 34

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$148.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$90.34M	USD	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$76.08M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$113.28M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.41M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$48.97M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$266.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$252.59M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$193.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$152.24M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	374.25M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	376.04M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$300.36M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$272.47M	USD	Point-in-time
Goodwill	`Goodwill`	$1.20B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	376.04M	shares	Point-in-time
Goodwill	`Goodwill`	$1.25B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	374.25M	shares	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$11.42M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$3.45M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.73B	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.66B	USD	Point-in-time
Total assets	`Assets`	$1.93B	USD	Point-in-time
Total assets	`Assets`	$1.98B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.95M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.15M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$61.58M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$60.00M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$29.30M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$26.51M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$10.82M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$14.12M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.63M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$116.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$112.27M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$157.42M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$212.04M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$50.33M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$66.96M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$3.31M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$1.48M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$54.28M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$55.41M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$265.33M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$335.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$382.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$448.16M	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of September 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of September 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of September 30, 2022 and December 31, 2021; 376,042 and 374,255 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.76M	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of September 30, 2022 and December 31, 2021; 376,042 and 374,255 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.74M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.90B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.05B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$3.19M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-357.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-525.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.55B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.53B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.98B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.93B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
TOTAL REVENUE	`Revenues`	$217.56M	USD	1 Quarter
TOTAL REVENUE	`Revenues`	$630.18M	USD	3 Qtrs
TOTAL REVENUE	`Revenues`	$477.52M	USD	3 Qtrs
TOTAL REVENUE	`Revenues`	$173.84M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$121.78M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$157.27M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$330.26M	USD	3 Qtrs
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$455.86M	USD	3 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$281.07M	USD	3 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$81.25M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$288.18M	USD	3 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$162.94M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$50.31M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$13.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$38.78M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$17.88M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$794.34M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$650.11M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$256.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$298.50M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-172.59M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-124.67M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-164.16M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-38.84M	USD	1 Quarter
Gain (loss) on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-906.00K	USD	1 Quarter
Gain (loss) on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-1.46M	USD	3 Qtrs
Gain (loss) on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$562.00K	USD	3 Qtrs
Gain (loss) on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$1.18M	USD	1 Quarter
Transaction costs	`TransactionCosts`	$210.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$126.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$507.00K	USD	3 Qtrs
Transaction costs	`TransactionCosts`	$3.66M	USD	3 Qtrs
Interest expense	`InterestExpense`	$3.50M	USD	1 Quarter
Interest expense	`InterestExpense`	$35.31M	USD	3 Qtrs
Interest expense	`InterestExpense`	$14.76M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.19M	USD	1 Quarter
Other expense	`OtherExpenses`	-	USD	1 Quarter
Other expense	`OtherExpenses`	$1.45M	USD	3 Qtrs
Other expense	`OtherExpenses`	$144.00K	USD	3 Qtrs
Other expense	`OtherExpenses`	$144.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-4.54M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-14.85M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-41.87M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-3.37M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-129.20M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-214.47M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-42.21M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-179.01M	USD	3 Qtrs
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-8.75M	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-10.11M	USD	3 Qtrs
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-4.35M	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-15.30M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-37.85M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-199.17M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-120.45M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-168.91M	USD	3 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	3 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	3 Qtrs
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-235.92M	USD	3 Qtrs
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-37.85M	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-120.45M	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-168.91M	USD	3 Qtrs
NET LOSS PER SHARE, BASIC	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.35	USD	1 Quarter
NET LOSS PER SHARE, BASIC	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.11	USD	1 Quarter
NET LOSS PER SHARE, BASIC	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.73	USD	3 Qtrs
NET LOSS PER SHARE, BASIC	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.48	USD	3 Qtrs
NET LOSS PER SHARE, DILUTED	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.48	USD	3 Qtrs
NET LOSS PER SHARE, DILUTED	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.73	USD	3 Qtrs
NET LOSS PER SHARE, DILUTED	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.11	USD	1 Quarter
NET LOSS PER SHARE, DILUTED	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.35	USD	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	321,283.00	shares	3 Qtrs
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	357,520.00	shares	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	354,057.00	shares	3 Qtrs
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	343,394.00	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-37.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-199.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-120.45M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-168.91M	USD	3 Qtrs
Unrealized gains on cash flow hedge, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	1 Quarter
Unrealized gains on cash flow hedge, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	3 Qtrs
Unrealized gains on cash flow hedge, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$3.19M	USD	1 Quarter
Unrealized gains on cash flow hedge, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$3.19M	USD	3 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-199.17M	USD	3 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-165.72M	USD	3 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-34.67M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-120.45M	USD	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-199.17M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-168.91M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$50.31M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$13.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$38.78M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$17.88M	USD	1 Quarter
Stock and unit-based compensation	`ShareBasedCompensation`	$152.24M	USD	3 Qtrs
Stock and unit-based compensation	`ShareBasedCompensation`	$150.81M	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-3.38M	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-5.62M	USD	3 Qtrs
Amortization of discount and debt issue costs	`AmortizationOfFinancingCosts`	$1.35M	USD	3 Qtrs
Amortization of discount and debt issue costs	`AmortizationOfFinancingCosts`	$1.50M	USD	3 Qtrs
(Gain) loss on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$562.00K	USD	3 Qtrs
(Gain) loss on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$-1.46M	USD	3 Qtrs
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	$-144.00K	USD	3 Qtrs
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Endowment of shares to LifeStance Health Foundation	`EndowmentOfShares`	$9.00M	USD	3 Qtrs
Endowment of shares to LifeStance Health Foundation	`EndowmentOfShares`	-	USD	3 Qtrs
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$34.61M	USD	3 Qtrs
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$20.71M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.81M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$32.89M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.11M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.61M	USD	3 Qtrs
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$15.91M	USD	3 Qtrs
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$-588.00K	USD	3 Qtrs
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$18.82M	USD	3 Qtrs
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$13.09M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.21M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.87M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$55.81M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$68.87M	USD	3 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$40.29M	USD	3 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$58.70M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-109.17M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-114.51M	USD	3 Qtrs
Proceeds from initial public offering, net of underwriters discounts and commissions and deferred offering costs	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Proceeds from initial public offering, net of underwriters discounts and commissions and deferred offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$548.90M	USD	3 Qtrs
Issuance of common units to new investors	`ProceedsFromContributionsFromAffiliates`	-	USD	3 Qtrs
Issuance of common units to new investors	`ProceedsFromContributionsFromAffiliates`	$1.00M	USD	3 Qtrs
Proceeds from long-term debt, net of discount	`ProceedsFromIssuanceOfLongTermDebt`	$98.80M	USD	3 Qtrs
Proceeds from long-term debt, net of discount	`ProceedsFromIssuanceOfLongTermDebt`	$237.47M	USD	3 Qtrs
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	$2.36M	USD	3 Qtrs
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	$7.27M	USD	3 Qtrs
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$311.06M	USD	3 Qtrs
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$181.23M	USD	3 Qtrs
Prepayment for debt paydown	`PaymentsOfDebtExtinguishmentCosts`	$1.61M	USD	3 Qtrs
Prepayment for debt paydown	`PaymentsOfDebtExtinguishmentCosts`	-	USD	3 Qtrs
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$6.26M	USD	3 Qtrs
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$12.29M	USD	3 Qtrs
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$478.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$329.02M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$34.60M	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$193.29M	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-57.69M	USD	3 Qtrs
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.34M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$212.12M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.34M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$212.12M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$28.22M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$9.52M	USD	3 Qtrs
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$908.00K	USD	3 Qtrs
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$1.78M	USD	3 Qtrs
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$264.00K	USD	3 Qtrs
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$14.00K	USD	3 Qtrs
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$5.51M	USD	3 Qtrs
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$7.72M	USD	3 Qtrs
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$8.94M	USD	3 Qtrs
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$8.61M	USD	3 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	3 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	-	USD	3 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-37.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-199.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-120.45M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-168.91M	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockUnitsReleases`	$-37.00K	USD	3 Qtrs
Forfeitures, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-1.05M	USD	3 Qtrs
Forfeitures, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-865.00K	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$3.19M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$3.19M	USD	3 Qtrs
Issuance of common units	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	3 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	3 Qtrs
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Accretion of redeemable class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	3 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	$1.49M	USD	3 Qtrs
Issuance of common units for acquisitions of businesses	`IssuanceOfCommonUnitsForAcquisitionsOfBusinesses`	-	USD	3 Qtrs
Conversion of Redeemable Class A Units into common stock upon closing of initial public offering, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$71.75M	USD	3 Qtrs
Endowment of shares to the LifeStance Health Foundation, value	`StockIssuedDuringPeriodValueIssuedForServices`	$9.00M	USD	3 Qtrs
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$153.28M	USD	3 Qtrs
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$35.73M	USD	1 Quarter
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$120.69M	USD	1 Quarter
Stock and unit-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$150.81M	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.